Home

John E Gallina

CIK 1433032 · EVP & Chief Financial Officer · last filed 2026-07-07

John E Gallina is an EVP & Chief Financial Officer who has filed 37 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing, for ARAI, was dated Jul 7, 2026. Across all open-market trades the lifetime net is −$36.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $27.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$26.96M

Companies

6

Total Filings

37

Lifetime Open-Market Net

-$36.30M

Filer Profile

Reported Address
120 MONUMENT CIRCLE
INDIANAPOLIS, IN 46204
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARAI Director 18,202 $0.22 $4.0K $0 6 2026-07-07
CVS Director 582 $94.66 $55.1K $0 2 2026-05-15
ELV EVP & Chief Financial Officer 63,725 $418.72 $26.68M $0 1 2023-03-03
Elevance Health, Inc. (ANTM) Delisted EVP & Chief Financial Officer 46,857 $482.58 $22.61M -$24.09M 9 2022-03-03
ANTX EVP & Chief Financial Officer 40,510 $5.41 $219.2K -$5.65M 6 2018-03-07
Elevance Health, Inc. (WLP) Delisted SVP & Chief Accounting Officer 22,490 — — -$6.56M 13 2014-03-05

Recent Filings

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 ARAI Grant (A) — $0 EDGAR
2026-05-15 CVS Grant (A) — $0 EDGAR
2026-04-02 ARAI Grant (A) — $0 EDGAR
2026-03-20 CVS Grant (A) +582 $41.8K EDGAR
2026-01-05 ARAI Grant (A) — $0 EDGAR
2025-10-20 ARAI Grant (A) — $0 EDGAR
2025-10-08 ARAI Grant (A) +7,292 $0 EDGAR
2025-09-03 ARAI Grant (A) +8,549 $0 EDGAR
2023-03-03 ELV Mixed +7,544 -$2.46M EDGAR
2022-03-03 Elevance Health, Inc. (ANTM) Delisted Mixed +5,162 -$2.07M EDGAR
Showing 1–10 of 37
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.